Vestre Viken Hospital Trust
vestreviken.noLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
63
Active
24
Phase 3
1
Total enrollment
21,495
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| UV1 | — | — | — | — | — | 1 | |
| Sagramostim | — | — | — | — | — | 1 | |
| Anti-PD-1/PD-L1 treatment | — | — | — | — | — | 1 | |
| Polygenetic risk score | — | — | — | — | — | 1 |
Next readouts
- 2024-05-01
- 2025-07-01
Top conditions
- Cardiovascular Diseases4
- Osteoarthritis3
- Nurse's Role3
- Atrial Fibrillation3
- Heart Failure2
- Frailty2
- Quality of Life2
- Statin Adverse Reaction2
Frequently asked questions about Vestre Viken Hospital Trust
- How many clinical trials does Vestre Viken Hospital Trust have on ClinicalTrials.gov?
- Vestre Viken Hospital Trust is listed as the lead sponsor on 63 clinical trials in ClinicalTrials.gov, 24 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Vestre Viken Hospital Trust's trials are in Phase 3?
- 1 of Vestre Viken Hospital Trust's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Vestre Viken Hospital Trust focus on?
- Vestre Viken Hospital Trust's most-studied conditions on ClinicalTrials.gov are Cardiovascular Diseases, Osteoarthritis, Nurse's Role, Atrial Fibrillation, Heart Failure.
- When are Vestre Viken Hospital Trust's next clinical trial readouts?
- Vestre Viken Hospital Trust has 2 upcoming primary-completion readouts tracked here; the soonest is “Clinical Pilot Study for Personalized Risk-based Breast Cancer Screening”, expected around 2024-05-01.